Intestinal epithelial cells undergo differentiation as they move from the crypt to the villi, a process that is associated with up-and downregulation in expression of a variety of genes, including those involved in nutrient absorption. Whether the intestinal uptake process of vitamin B 2 [riboflavin (RF)] also undergoes differentiation-dependent regulation and the mechanism through which this occurs are not known. We used humanderived intestinal epithelial Caco-2 cells and native rat intestine as models to address these issues. Caco-2 cells showed a significantly higher carrier-mediated RF uptake in post-than preconfluent cells. This upregulation was associated with a significantly higher level of protein and mRNA expression of the RF transporters hRFVT-1 and hRFVT-3 in the post-than preconfluent cells; it was also accompanied with a significantly higher rate of transcription of the respective genes (SLC52A1 and SLC52A3), as indicated by the higher level of expression of heterogeneous nuclear RNA and higher promoter activity in post-than preconfluent cells. Studies with native rat intestine also showed a significantly higher RF uptake by epithelial cells of the villus tip than epithelial cells of the crypt; this again was accompanied by a significantly higher level of expression of the rat RFVT-1 and RFVT-3 at the protein, mRNA, and heterogeneous nuclear RNA levels. These findings show, for the first time, that the intestinal RF uptake process undergoes differentiation-dependent upregulation and suggest that this is mediated (at least in part) via transcriptional mechanisms.
. RF deficiency also occurs in patients with Brown-Vialetto-Van Laere syndrome, a neurological disorder that is caused by mutations in hRFVT-3, as well as in patients with esophageal squamous cell carcinoma and gastric cardia adenocarcinoma (1, 6, 9, 24, 38, 45) . In these patients, RF supplementation significantly improves symptoms and biochemical abnormalities (1, 6, 16, 45) .
Humans and other mammals cannot synthesize RF endogenously and, therefore, must obtain the micronutrient from exogenous sources via intestinal absorption. The intestinal epithelium, therefore, plays an essential role in determining and regulating the normal level of RF in the body. Previous studies from our laboratory and others utilized a variety of human and animal intestinal preparations and showed that the intestinal absorption process of dietary RF in the small intestine is via a specific carrier-mediated mechanism (reviewed in Refs. 34 and 35) . The molecular identity of the systems involved in this absorptive event has only recently begun to emerge as a result of cloning of the RF transporters (RFVT-1, RFVT-2, and RFVT-3) from a variety of human and animal tissues (48 -50) . hRFVT-1 and hRFVT-3 share 43% identity at the amino acid level with one another, while hRFVT-2 shares ϳ87 and 44% identity with hRFVT-1 and hRFVT-3, respectively (49) . RFVT-1 and RFVT-3 (products of the SLC52A1 and SLC52A3 genes, respectively) are expressed at the basolateral and brush border membrane domains of the polarized enterocytes, respectively, and appear to facilitate the vectorial transport of RF from the lumen into the circulation (40) .
Intestinal epithelial cells undergo differentiation, which transforms the cells from an immature (undifferentiated) state to a mature (differentiated) state. This event occurs as the cells move upward from their place of birth in the crypt to the villus region and is associated with up-and downregulation of expression of a variety of genes, including those involved in nutrient (vitamin) absorption (7, 11, 22, 23, 25, 26, 39, 47) . This differentiation-dependent regulation of expression of membrane carriers is designed to achieve and maintain normal function of intestinal epithelia. Understanding the mechanisms involved in regulation may assist in the design of effective strategies to promote faster recovery of intestinal epithelial injury, which occurs under certain pathophysiological conditions and as a result of use of certain pharmacological agents (e.g., certain anticancer drugs); therefore, addressing this issue in the case of RF is of physiological significance and may have therapeutic potential. Nothing is known about possible regulation of intestinal RF uptake during differentiation and the molecular mechanism involved; thus these aspects were investigated in this study. We use as models the intestinal epithelial Caco-2 cells [which differentiate spontaneously in culture upon reaching confluence (4, 7, 17) ] and native rat intestine. Our results show that the intestinal RF uptake process is upregulated as the intestinal epithelial cells are transformed from the undifferentiated to the differentiated state and that this differentiation-dependent regulation is mediated, at least in part, via transcriptional regulatory mechanism(s) involving the SLC52A1 and SLC52A3 genes.
MATERIALS AND METHODS

Materials. [
3 H]RF (specific activity 21.2 Ci/mmol, radiochemical purity 98%) was obtained from Moravek Biochemicals (Brea, CA). Oligonucleotide primers were obtained from Sigma Genosys (The Woodlands, TX). All other chemicals and reagents were of analytical/ molecular biology grade and were obtained from commercial sources.
Caco-2 cell culture and RF uptake assay. Human-derived intestinal epithelial Caco-2 cells, a well-established model for studying differentiation-related aspects of intestinal epithelia (7, 11, 22, 23, 25, 26, 39, 47) , were obtained from American Type Culture Collection (Manassas, VA) and grown in a modified Eagle's medium (American Type Culture Collection) supplemented with 10% (vol/vol) fetal bovine serum and appropriate antibiotics. Cells were plated at a density of 2 ϫ 10 5 cells/well onto 12-well plates (Corning, Corning, NY). Uptake assays [initial rate 3 min (36)] were performed on preconfluent (1 day after seeding) and postconfluent (5 days after seeding, i.e., 3 days after confluence) Caco-2 cells. [ 3 H]RF uptake was measured at 37°C in Krebs-Ringer buffer (pH 7.4), as described previously (26, 36, 39) . Total protein content was determined using a protein assay kit (Bio-Rad, Hercules, CA).
Isolation of villus and crypt cells from rat small intestine and uptake assay. An established fractionation procedure (29) was used to isolate villus and crypt intestinal epithelial cells from the proximal half of rat small intestine, as described elsewhere (26, 37, 46) . For this fractionation method, 10 factions were collected, with fractions 1 and 2 representing upper villus (mature/differentiated) epithelial cells and fractions 9 and 10 representing crypt (immature/undifferentiated) cells. Purity of these villus and crypt fractions has been established previously using marker enzymes (alkaline phosphatase and thymidine kinase for villus and crypt epithelial cells, respectively) (26) . A rapid-filtration method (18) Western blot analysis. RIPA buffer (Sigma, St. Louis, MO) was used to isolate total protein from pre-and postconfluent Caco-2 cells, as well as from rat small intestinal crypt and villus cells. Proteins (60 g) were resolved onto premade 4 -12% Bis-Tris minigel (Invitrogen, Carlsbad, CA) and subjected to Western blot analysis, as described previously (27, 43) . After electrophoresis, proteins were electroblotted onto a polyvinylidene difluoride membrane (Immobilon, Fisher Scientific, Fremont, CA). Along with blocking buffer (LI-COR Bioscience, Lincoln, NE), the membranes were also incubated overnight with human RF transporters [hRFVT-1 (Abnova, Walnut, CA) and hRFVT-3 (Thermo Fisher Scientific, Fremont, CA)] and rat RF transporters [rRFVT-1 (Sigma) and rRFVT-3 (Santa Cruz Biotechnology, Santa Cruz, CA)] specific polyclonal antibodies and the respective ␤-actin monoclonal antibody (Santa Cruz Biotechnology). Specificity of the rat and human RFVT-1 bands has been previously established by overexpression of a green fluorescent protein-RFVT-1 construct in cells, followed by use of a green fluorescent protein monoclonal antibody (data not shown). Specificity of the rRFVT-3 band was determined using antigenic peptide (Santa Cruz Biotechnology) (data not shown), and specificity of the hRFVT-3 band was determined as described elsewhere (27) . The immunoreactive bands were detected and quantified as described elsewhere (27, 43) .
Real-time PCR. Total RNA was isolated from pre-and postconfluent Caco-2 cells, as well as from rat jejunum villus and crypt cells. The DNase I-treated RNA was reverse-transcribed using the iScript cDNA synthesis kit (Bio-Rad), and real-time PCR was performed using combinations of gene-specific primers (hRFVT-1, hRFVT-3, rRFVT-1, rRFVT-3, ␤-actin, and 18S; Table 1 ). Real-time PCR and determination of the relative level of mRNA expression of hRFVT-1 and RFVT-3 in pre-and postconfluent Caco-2 cells and rRFVT-1 and RFVT-3 in rat intestinal villus and crypt cells were performed as described elsewhere (21).
Table 1. Combination of primers used to amplify the respective genes by real-time PCR, semiquantitative PCR, and cloning of the promoters
Primers (5=-3=)
Gene
Forward Reverse
PCR primers
hRFVT-1 AAAAGACCTTCCAGAGGGTTG AGCACCTGTACCACCTGGAT hRFVT-3 CCTTTCCGAAGTGCCCATC AGAAGGTGGTGAGGTAGTAGG Human ␤-actin AGCCAGACCGTCTCCTTGTA TAGAGAGGGCCCACCACAC rRFVT-1 AGCTACCTGTAGTGGTGA CTCAGCCCCTGAACCA rRFVT-3 TAAGGAAGATCACGGGCACCTC GTCATCCAACTGGCCAACACAG 18S GGGAGGTAGTGACGAAAAATAACAAT TTGCCCTCCAATGGATCCTC hnRNA primers hRFVT-1 GACCTGCCTGTGAC AACCCTCTGGAAGG hRFVT-3 TGACATCGCACAGG CCTGCTGTTGATCTG Human ␤-actin TTCCTGGGTGAGTGGAG GGACTCCATGCCTGAGAG rRFVT-1 CTTTAGGCCAGCTTCTTG AAAATGCGAGTGGACAG rRFVT-3 TGGTGTTCTGCCCTCAG GGGCCTGTGTTTGTAGC Rat ␤-actin CTGCTCTTTCCCAGATGAG CTCATAGATGGGCACAGTG
Primers used for cloning of hRFVT-3 promoter
hRFVT-3 CGACGCGTTTGATCAAATCCTGGTTG CCGCTCGAGCTTCTTCCTTCTAGTACAAAGC
hRFVT and rRFVT, human and rat riboflavin (RF) transporters, respectively; hnRNA, heterogeneous nuclear RNA.
Generation of hRFVT-3 (SLC52A3) full-length promoter construct and assay of promoter activity.
The transcriptional start site for the hRFVT-3 gene was determined by means of 5=-RACE (rapid amplification of cDNA ends) using a kit from Life Technologies (RACE version 2.0 kit, Invitrogen). Genome analysis for hRFVT-3 reveals that it has one 5=-untranslated exon, and the putative ATG translational start site is located in exon 2. The transcriptional start site was determined by isolation of the total RNA from Caco-2 cells and synthesis of first-strand cDNA using gene-specific antisense primer (5=-TAGAGACACGCTAAC-3=), which is complementary to nucleotides 88 -73 bp upstream from the putative ATG start of translation codon in mRNA. The first strand was isolated and deoxycytosinetailed following the manufacturer's protocol. PCR was performed using abridged anchor primer (provided with the kit) and a second gene-specific reverse primer (5=-ATGGGAGACGAGGTCCGAAG-3=), which is complementary to nucleotides 109 -132 bp upstream from the ATG codon. The PCR product was further subjected to nested PCR using a third gene-specific primer (5=-GCTCTC-CTGGGATCTGGACTG-3=) complementary to nucleotides 142-165 bp upstream from the ATG codon. The PCR product was cloned in pGEM T Easy vector and sequenced (Laragen, Culver City, CA). We identified the hRFVT-3 transcriptional start site located 2,710 bp upstream from the ATG codon. We used human genomic DNA (Clontech) and gene-specific primers (Table 1 ) designed to amplify a ϳ3.1-kb fragment of DNA, including the transcriptional start site, to clone the region 5,832 to 2,698 bp upstream from the ATG codon in pGL3-basic vector. Gene-specific sequence was obtained from GenBank (GI 306518672 for hRFVT-3). The PCR amplification was performed as described elsewhere (39), gel-purified using a GENECLEAN II kit (MP Biomedicals, Solon, OH), and subcloned into the TA vector (Promega, Madison, WI) and then into the promoterless pGL3-basic vector (Promega) using enzymes MluI and HindIII for hRFVT-3. Sequence of the hRFVT-3 promoter was verified by sequencing (Laragen). The hRFVT-3 full-length promoterluciferase reporter construct (4 g), along with 100 ng of the transfection control plasmid Renilla luciferase-thymidine kinase (Promega), was transiently cotransfected into Caco-2 cells grown in 12-well plates at Ͻ50% confluence using Lipofectamine 2000 reagent (Invitrogen). Caco-2 cells were lysed 24 h after transfection (preconfluence) and at 3 days after reaching confluence (postconfluence), and Renilla-normalized firefly luciferase activity was measured using the Dual-Luciferase assay kit (Promega) and luminometer (Promega, Sunnyvale, CA) (26, 39) .
Heterogeneous nuclear RNA analysis. Level of heterogeneous nuclear RNA (hnRNA) is used as a measure of transcriptional activity of a given gene under different conditions (2, 10, 20, 41, 42) . The RNA samples were treated with DNase I to avoid amplification of genomic DNA and reverse-transcribed with the random hexamer (Invitrogen). Using cDNA (synthesized from RNA) and gene-specific hnRNA primers that anneal to sequences in the intron/exon boundaries (Table 1) , we determined the level of expression of human and rat RFVT-1 and RFVT-3 hnRNA in pre-and postconfluent Caco-2 cells and in rat villus and crypt epithelial cells. Real-time and semiquantitative PCR were performed as described previously (41, 42) . The real-time PCR data for hRFVT-1 and hRFVT-3 were determined as described elsewhere (41, 42) . The amplified rRFVT-1 and rRFVT-3 and ␤-actin hnRNA products were analyzed by agarose gel electrophoresis, and the appropriate bands were quantified using UN-SCAN-IT gel digitizing software (Silk Scientific, Orem, UT).
Statistical analysis. promoter experiments were performed on at least three different occasions using different sample preparations. Figure 1 depicts the effect of differentiation of Caco-2 cells on the initial rate of carrier-mediated [
RESULTS
Effect of differentiation on physiological and molecular parameters of RF uptake by human-derived intestinal epithelial Caco-2 cells.
3 H]RF (14 nM) uptake. A significantly (P Ͻ 0.01) higher carriermediated RF uptake was observed in postconfluent (differentiated) than preconfluent (undifferentiated) Caco-2 cells. Figure 2 shows the effect of differentiation on the expression level of hRFVT-1 and hRFVT-3 proteins in Caco-2 cells. We focused on hRFVT-1 and hRFVT-3, since they represent the systems that transport RF across the basolateral and apical membrane domains of the enterocyte, respectively (40) . The results showed that the level of expression of the hRFVT-1 and hRFVT-3 proteins was significantly (P Ͻ 0.05 and P Ͻ 0.01, respectively) higher in post-than preconfluent Caco-2 cells (Fig. 2) . In another study, we examined the effect of differentiation on the level of expression of the hRFVT-1 and hRFVT-3 mRNA and observed a significantly (P Ͻ 0.05 and P Ͻ 0.01, respectively) higher expression of both transporters in post-than preconfluent Caco-2 cells (Fig. 3) .
To explore the effect of differentiation on transcriptional activities of the SLC52A1 and SLC52A3 genes (which encode hRFVT-1 and hRFVT-3, respectively), we used real-time PCR to examine the level of hnRNA of hRFVT-1 and hRFVT-3 in pre-and postconfluent Caco-2 cells. The hnRNA represents the first product of gene transcription, and its level reflects transcriptional activity of the particular gene (2, 10, 20, 41, 42) . The results showed a significantly (P Ͻ 0.01 for hRFVT-1 and P Ͻ 0.05 for hRFVT-3) higher level of expression of the hRFVT-1 and hRFVT-3 hnRNA in post-than preconfluent Caco-2 cells (Fig. 4, A and B) . These results suggest that the differentiation-dependent upregulation of the expression of hRFVT-1 and hRFVT-3 is, at least in part, mediated by an increase in the transcriptional activity of the respective gene. To further confirm this, we focused on the hRFVT-3 system, since it is the predominant and most efficient RF transport system expressed in the human small intestine and appears to play a key role in intestinal RF uptake (40) , and cloned and sequenced the 5=-regulatory region (ϳ3.1 kb) of its gene (i.e., SLC52A3). We then examined the effect of differentiation of Caco-2 cells on the activity of the SLC52A3 promoter (attached to the firefly luciferase reporter gene) after transient transfection into Caco-2 cells. The results showed a significantly (P Ͻ 0.01) higher SLC52A3 promoter activity in post-than preconfluent Caco-2 cells (Fig. 4C) . This finding further supports the suggestion that the increase in expression of RF transporters with differentiation is mediated, at least in part, via transcriptional mechanism(s).
Effect of differentiation on physiological and molecular parameters of RF uptake by native rat intestine: studies using freshly isolated intestinal crypt and villus epithelial cells.
To validate the physiological relevance of the above-described findings with cultured Caco-2 cells, we used native rat intestine in these investigations. Immature crypt and mature villus epithelial cells were isolated from rat proximal small intestine and used fresh to study the initial rate of carrier-mediated [ 3 H]RF (24 nM) uptake (36) . The results showed a significantly (P Ͻ 0.05) higher carrier-mediated RF uptake in intestinal villus than crypt epithelial cells (Fig. 5 ).
We also examined the level of expression of the rRFVT-1 and rRFVT-3 proteins in rat intestinal crypt and villus cell preparations by Western blotting using specific polyclonal antibodies. The results showed a significantly (P Ͻ 0.05 and P Ͻ 0.01, respectively) higher level of expression of the rRFVT-1 and rRFVT-3 proteins in intestinal villus than crypt epithelial cells (Fig. 6) . Level of expression of rRFVT-1 and rRFVT-3 mRNA in rat intestinal crypt and villus epithelial cells was also determined by means of PCR, with the results showing a significantly (P Ͻ 0.05 for both) higher level of expression of rRFVT-1 and rRFVT-3 mRNA in intestinal villus than crypt epithelial cells (Fig. 7) . Finally, we examined the level of expression of rRFVT-1 and rRFVT-3 hnRNA in rat intestinal crypt and villus epithelial cells to gain an insight into the transcriptional activities of the Slc52a1 and Slc52a3 genes. Results of semiquantitative PCR showed a significantly (P Ͻ 0.01 for both) higher level of expression of rRFVT-1 and rRFVT-3 hnRNA in villus than crypt epithelial cells (Fig. 8 ). These findings with native rat intestine again suggest that the differentiation-dependent regulation of intestinal RF uptake is mediated, at least in part, via transcriptional mechanism(s).
DISCUSSION
Our aim in this investigation was to study whether the intestinal RF uptake process undergoes differentiation-dependent regulation and, if so, to shed light onto the physiological and molecular mechanisms involved in such regulation. It is well established that differentiation of intestinal epithelial cells is associated with changes in levels of expression of many genes, including those involved in nutrient (vitamins) uptake (11, 23, 26, 39) . We used the human-derived cultured intestinal epithelial Caco-2 cells in our investigations, since they differentiate spontaneously in culture after reaching confluence and acquire a phenotype that closely reflects the mature absorptive enterocyte (4, 7, 17) ; indeed, a large number of studies have used these cells in such investigations (7, 23, 26, 39, 44, 47) . We complemented our findings using this cultured cell model with studies utilizing freshly isolated rat native intestinal epithelial cells. Our studies with Caco-2 cells showed a significantly higher RF uptake by postconfluent (differentiated) than preconfluent (undifferentiated) cells, clearly suggesting that the uptake process is under a differentiation-dependent type of regulation. This was associated with a higher level of expression of hRFVT-1 and hRFVT-3 at the protein and mRNA levels in the former than the latter cell type. The latter findings suggest possible involvement of a transcriptional mechanism(s) in mediating, at least part, the differentiation-dependent effect on the intestinal RF uptake process. The findings that the level of expression of the hnRNA of hRFVT-1 and hRFVT-3 is higher in post-than preconfluent Caco-2 cells support this suggestion, because the level of hnRNA (the first product of gene transcription) reflects the transcription rate of the relevant gene and, thus, has been used as an indicator for involvement of transcriptional mechanism(s) in changes in gene expression under different conditions (2, 10, 20, 41, 42) . Involvement of transcriptional mechanism(s) in mediating, at least part, the differentiation-dependent regulation of intestinal RF uptake was further confirmed by the finding of activity of the SLC52A3 full-length promoter expressed in pre-and postconfluent Caco-2 cells: a significantly higher SLC52A3 promoter activity was found in post-than preconfluent Caco-2 cells. Further studies are required to determine the differentiation-dependent responsive region in the SLC52A3 promoter of the RF transporter and the cis-and trans-acting elements that mediate the differentiation-dependent effect.
The results with native rat intestinal epithelial cells complemented the findings with cultured Caco-2 cells, in that a significantly higher carrier-mediated RF uptake was observed in intestinal villus (differentiated) than crypt (undifferentiated) cells. This was again associated with a higher level of expression of rRFVT-1 and rRFVT-3 at the protein and mRNA levels in the mature villus than immature crypt epithelial cells. Also, the level of expression of rRFVT-1 and rRFVT-3 hnRNA was higher in villus than crypt epithelial cells. These findings again suggest possible involvement of a transcriptional mechanism(s) in mediating the differentiation-dependent regulatory effect on the intestinal RF uptake process.
Collectively, these findings demonstrate, for the first time, that the intestinal RF uptake process undergoes differentiationdependent regulation and suggest that this regulation is, at least in part, mediated via a transcriptional mechanism(s).
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